Biomarkers for breast cancer
作者： Jinong Li , Xiao-Ying Meng , Daniel W. Chan , Eric Thomas Fung , Zhen Zhang
DOI:
关键词:
摘要: Abstract not available for EP1802764Abstract of corresponding document: WO2006034032The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying breast cancer status a patient. In particular, the this to classify subject sample as or non-breast cancer. The can be detected by SELDI mass spectrometry.
google.de 参考文章(19)
Jinong Li, Daniel W. Chan, Zhen Zhang, Use of biomarkers to detect breast cancer ,(2003)
George Jackowski, John Marshall, Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance ,(2006)
Charles F. Streckfus, Lenora G. Bigler, James Tate Thigpen, Method of diagnosing and monitoring malignant breast carcinomas ,(2000)
John D. Shaughnessy, Bart Barlogie, Fenghuang Zhan, Diagnosis, Prognosis and Identification of Potential Therapeutic Targets of Multiple Myeloma Based on Gene Expression Profiling ,(2013)
Antonia Vlahou, George L Wright, Biomarkers of transitional cell carcinoma of the bladder ,(2001)
Anne Mary Freeman, Richard Anthony Godwin Smith, Ian Dodd, Danuta Ewa Irena Mossakowska, Soluble CR1 derivatives ,(1993)
James L. Wittliff, Xiao-Jun Ma, Wei Wang, Mark G. Erlander, Breast cancer signatures ,(2004)
Praveen Sharma, Anders Lonneborg, Oligonucleotides for cancer diagnosis ,(2005)
Xiao-Ying Meng, Daniel W. Chan, Zhen P. Zhang, Eric Fung, Use of biomarkers for detecting ovarian cancer ,(2003)
Emilia Caputo, Maria Luisa Lombardi, Vincenza Luongo, Ramy Moharram, Pete Tornatore, Giuseppe Pirozzi, John Guardiola, Brian M. Martin, Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques. Journal of Chromatography B. ,vol. 819, pp. 59- 66 ,(2005) , 10.1016/J.JCHROMB.2005.01.022